MURAMAKI Mototsugu 村蒔基次

… Alternative Names

MURAMAKI Mototugu 村蒔基次

Less

Researcher Number	10448178
Other IDs
Affiliation (based on the past Project Information) *help	2016: 神戸大学, 医学研究科, 医学研究員 2015: 神戸大学, 医学(系)研究科(研究院), 研究員 2012 – 2014: 神戸大学, 医学部附属病院, 講師 2011: 神戸大学, 医学部附属病院, 助教 2009: Kobe University, 医学部附属病院, 助教 2008: Kobe University, 医学部・附属病院, 医員
Review Section/Research Field	Principal Investigator Urology
Keywords	Principal Investigator 上皮間葉転換 / 膀胱癌 / クラスタリン / 上皮間葉移行 / 去勢抵抗性前立腺癌 / 前立腺癌 / N-cadheri / 腎盂癌 / E-cadhein / E-cadherin … More / N-cadherin / 尿路上皮癌 / Clusterin / in vivo study / アポトーシス / 分子標的治療 / 抗癌剤耐性 / ジェムシタビン / 分子標的薬 / ジェムシタビン抵抗性 Less

Molecular mechanism of epithelial-mesenchymal transition in castration resistant prostate cancer.Principal Investigator
- Principal Investigator
  
  Muramaki Mototsugu
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Kobe University
The role of EMT on malignant progression of urothelial carcinoma.Principal Investigator
- Principal Investigator
  
  MURAMAKI Mototsugu
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Kobe University
Enhancement of chemo-sensitivity by molecular-targeting drugs in gemcitabine-resistant advanced bladder cancer.Principal Investigator
- Principal Investigator
  
  MURAMAKI Mototugu
- Project Period (FY)
  2008 – 2009
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Urology
- Research Institution
  Kobe University

All 2016 2014 2013 2012 2011 2009 2007 Other

All Journal Article Presentation

[Journal Article] Antisense Oligonucleotide therapy for patients with castration-resistant prostate cancer2016
- Author(s)
  Muramaki　M,Miyake H,Fujisawa M
- Journal Title
  
  Nihon Rinsho
  
  Volume: 20 Pages: 234-7
- NAID
  40018884107
- Data Source
  KAKENHI-PROJECT-26462412
[Journal Article] Assessment of postoperative quality of life: comparative study between laparoscopic and minimum incision endoscopic radical prostatectomies.2014
- Author(s)
  Muramaki M1, Miyake H, Behnsawy HM, Furukawa J, Harada K, Fujisawa M.
- Journal Title
  
  Int J Clin Oncol.
  
  Volume: 19 Issue: 6 Pages: 10921097-10921097
- DOI
  10.1007/s10147-013-0659-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26462412
[Journal Article] Expression profile of E-cadherin and N-cadherin in non-muscle-invasive bladder cancer as a novel predictor of intravesical recurrence following transurethral resection2012
- Author(s)
  Muramaki M, Miyake H, Terakawa T, Kumano M, Sakai I, Fujisawa M
- Journal Title
  
  Urol Oncol
  
  Volume: 30(2) Pages: 6-161
- Data Source
  KAKENHI-PROJECT-23592331
[Journal Article] Expression profile of E-cadherin and N-cadherin in urothelial carcinoma of the upper urinary tract is associated with disease recurrence in patients undergoing nephroureterectomy.2012
- Author(s)
  Mototsugu Muramaki
- Journal Title
  
  Urology
  
  Volume: 78 Issue: 6 Pages: 1443-1443
- DOI
  10.1016/j.urology.2011.07.1388
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23592331
[Journal Article] Chemosensitization of gemcitabine-resistant human bladder cancer cell line both in vitro and in vivo using antisense oligonucleotide targeting the anti-apoptotic gene, clusterin.2009
- Author(s)
  Muramaki M, So A, Hayashi N, Sowery R, Miyake H, Fujisawa M, Gleave ME.
- Journal Title
  
  BJU Int. 103(3)
  
  Pages: 384-390
- Data Source
  KAKENHI-PROJECT-20791108
[Journal Article] Chemosensltization of gemeltablne-reslstant human bladder cancer cell line both in vitro and in vivo using antisense oligonucleotide targeting the anti-apoptotic gene, clusterin2009
- Author(s)
  Muramaki M, So A, Hayashi N, Sowery R, Miyake H, Fujisawa M, Gleave ME
- Journal Title
  
  BJU Int 103
  
  Pages: 384-390
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20791108
[Journal Article] Expression profile of E-cadherin and N-cadherin in urothelial carcinoma of the upper urinary tract is associated with disease recurrence in patients undergoing nephroureterectomy
- Author(s)
  Muramaki M, Miyake H, Terakawa T, Kusuda Y, Fujisawa M
- Journal Title
  
  Urology
  
  Volume: 78(6) Pages: 1443-1443
- Data Source
  KAKENHI-PROJECT-23592331
[Presentation] Expression profile of E-cadherin, N-cadherin and P-cadherin in renal cell carcinoma as prognostic indicators.2014
- Author(s)
  Mototsugu Muramaki
- Organizer
  Annual congress of Eurpean Association of Urology
- Place of Presentation
  Stockholm
- Data Source
  KAKENHI-PROJECT-23592331
[Presentation] Expression profile of E-cadherin, N-cadherin and P-cadherin in localized prostate cancer as prognostic indicators2013
- Author(s)
  村蒔基次
- Organizer
  2013癌学会総会
- Place of Presentation
  京都
- Year and Date
  2013-10-05
- Invited
- Data Source
  KAKENHI-PROJECT-23592331
[Presentation] Expression profile of E-cadherin, N-cadherin and P-cadherin in renal cell carcinoma as prognostic indicators.2013
- Author(s)
  村蒔　基次
- Organizer
  日本癌学会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-23592331
[Presentation] Expression profile of E-cadherin, N-cadherin and P-cadherin in renal cell carcinoma as prognostic indicators.2012
- Author(s)
  村蒔基次
- Organizer
  日本癌学会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-23592331
[Presentation] Expression profile of E-cadherin, N-cadherin and P-cadherin in renal cell carcinoma as prognostic indicators2012
- Author(s)
  村蒔基次
- Organizer
  2012癌学会総会
- Place of Presentation
  札幌
- Year and Date
  2012-09-20
- Invited
- Data Source
  KAKENHI-PROJECT-23592331
[Presentation] Expression profile of E-cadherin and N-cadherin in urothelial carcinoma of the upper urinary tract as a novel predictor of recurrence following nephroureterectomy2011
- Author(s)
  Mototsugu Muramaki
- Organizer
  American Urological Association, Annual meeting
- Place of Presentation
  Washington, DC
- Data Source
  KAKENHI-PROJECT-23592331
[Presentation] Chemosensitization of gemcitabine-resistant human bladder cancer cell line both in vitro and in vivo using antisense oligonucleotide targetting the anti-apoptotic gene, clusterin.2007
- Author(s)
  村蒔基次
- Organizer
  日本癌学会総会
- Place of Presentation
  clusterin
- Data Source
  KAKENHI-PROJECT-20791108
[Presentation] HIF-1 alpha expression in non-muscle invasive urothelial carcinoma of the bladder and its association with EMT markers.
- Author(s)
  村蒔基次、原田健一、古川順也、三宅秀明、藤澤正人
- Organizer
  日本癌学会総会
- Place of Presentation
  横浜
- Year and Date
  2014-09-25 – 2014-09-27
- Data Source
  KAKENHI-PROJECT-26462412

1. MIYAKE Hideaki (60379435)

# of Collaborated Projects: 2 results

# of Collaborated Products: 5 results

MURAMAKI Mototsugu 村蒔 基次

MURAMAKI Mototugu 村蒔 基次

Research Projects

Research Products

Co-Researchers

Molecular mechanism of epithelial-mesenchymal transition in castration resistant prostate cancer.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

The role of EMT on malignant progression of urothelial carcinoma.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Enhancement of chemo-sensitivity by molecular-targeting drugs in gemcitabine-resistant advanced bladder cancer.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Antisense Oligonucleotide therapy for patients with castration-resistant prostate cancer2016

Author(s)

Journal Title

NAID

Data Source

[Journal Article] Assessment of postoperative quality of life: comparative study between laparoscopic and minimum incision endoscopic radical prostatectomies.2014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Expression profile of E-cadherin and N-cadherin in non-muscle-invasive bladder cancer as a novel predictor of intravesical recurrence following transurethral resection2012

Author(s)

Journal Title

Data Source

[Journal Article] Expression profile of E-cadherin and N-cadherin in urothelial carcinoma of the upper urinary tract is associated with disease recurrence in patients undergoing nephroureterectomy.2012

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Chemosensitization of gemcitabine-resistant human bladder cancer cell line both in vitro and in vivo using antisense oligonucleotide targeting the anti-apoptotic gene, clusterin.2009

Author(s)

Journal Title

Data Source

[Journal Article] Chemosensltization of gemeltablne-reslstant human bladder cancer cell line both in vitro and in vivo using antisense oligonucleotide targeting the anti-apoptotic gene, clusterin2009

Author(s)

Journal Title

Data Source

[Journal Article] Expression profile of E-cadherin and N-cadherin in urothelial carcinoma of the upper urinary tract is associated with disease recurrence in patients undergoing nephroureterectomy

Author(s)

Journal Title

Data Source

[Presentation] Expression profile of E-cadherin, N-cadherin and P-cadherin in renal cell carcinoma as prognostic indicators.2014

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] Expression profile of E-cadherin, N-cadherin and P-cadherin in localized prostate cancer as prognostic indicators2013

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Expression profile of E-cadherin, N-cadherin and P-cadherin in renal cell carcinoma as prognostic indicators.2013

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] Expression profile of E-cadherin, N-cadherin and P-cadherin in renal cell carcinoma as prognostic indicators.2012

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] Expression profile of E-cadherin, N-cadherin and P-cadherin in renal cell carcinoma as prognostic indicators2012

Author(s)

Organizer

Place of Presentation

Year and Date

MURAMAKI Mototsugu 村蒔基次

MURAMAKI Mototugu 村蒔基次